Skip to content
PharmaInsight

Co-beneldopa (Benserazide/levodopa) vs Tafamidis meglumine (old)

National NHS prescribing compared (Prescription Cost Analysis)
Data updated March 2026

Co-beneldopa (Benserazide/levodopa) was dispensed 79,414.0× as often as Tafamidis meglumine (old) in March 2026 — 79,414 items versus 1 in England.

79,414items

Co-beneldopa (Benserazide/levodopa) · March 2026

NHSBSA Prescription Cost Analysis

1items

Tafamidis meglumine (old) · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Co-beneldopa (Benserazide/levodopa) versus Tafamidis meglumine (old): national items dispensed by month

▬ Co-beneldopa (Benserazide/levodopa)   ·   ╌ Tafamidis meglumine (old)

Tafamidis meglum… 79,414

Source: NHSBSA Prescription Cost Analysis, to March 2026

Co-beneldopa (Benserazide/levodopa) versus Tafamidis meglumine (old), March 2026
Measure Co-beneldopa (Benserazide/levodopa) Tafamidis meglumine (old)
Items, March 2026 79,414 1
Items, last 12 months 949,699 1
Net ingredient cost, March 2026 £886,111 £712

See the full profile for Co-beneldopa (Benserazide/levodopa) or Tafamidis meglumine (old).